Video
Dr. Hsi discusses study on 24-hour urine testing in VA population
Author(s):
“The rates of testing declined slightly, about 2 absolute percentage points, over the study interval, despite the introduction of guidelines recommending it during the study period,” says Ryan Hsi, MD, FACS.
Video Player is loading.
In this interview, Ryan Hsi, MD, FACS, discusses key findings from his recent study, “Specialist care, metabolic testing, and testing completeness among U.S. veterans with urinary stone disease”. Hsi is an associate professor of urology at Vanderbilt University Medical Center in Nashville, Tennessee.
Newsletter
Stay current with the latest urology news and practice-changing insights — sign up now for the essential updates every urologist needs.
Related Videos
Investigators compare trimodal therapy vs cystectomy in MIBC
RX Review: Implementing mitomycin for LG-IR-NMIBC in clinical practice
RX Review: TURBT vs chemoablation for low-grade, intermediate-risk NMIBC
RX Review: A paradigm shift for low-grade, intermediate-risk NMIBC
RX Review: How mitomycin for intravesical solution works in treating LG-IR-NMIBC
RX Review: Redefining treatment for LG-IR-NMIBC
The Logistical Challenges in ccRCC Treatment
The Role of Genomic Classifiers in Guiding Therapy for Localized High-Risk Prostate Cancer
The Future of PET Imaging Agents
A 62-Year-Old Man With High-Risk Localized Prostate Cancer
Related Content
